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Introduction
The proper control of translation, mRNA degradation, and the 
subcellular localization of mRNAs are important aspects of the 
regulation of gene expression in eukaryotic cells. Eukaryotic 
mRNAs are typically degraded in a process initiated by de­
adenylation, which can lead to 3 to 5 degradation but often 
allows mRNA decapping and 5 to 3 degradation (Parker and 
Song, 2004; Garneau et al., 2007). Decapping is in competi­
tion with translation initiation (Coller and Parker, 2004) and 
occurs by a process involving a set of decapping activator and 
enhancer proteins that can inhibit translation and/or assemble a 
translationally repressed mRNP, which contains the decapping 
enzyme and is capable of decapping and 5 to 3 degradation 
(for review see Parker and Sheth, 2007).
mRNAs that are not engaged in translation can accumu­
late in a variety of RNA–protein granules in the cytosol. For 
example, untranslating mRNAs complexed with the decapping 
machinery accumulate in foci referred to as processing bod­
ies (P­bodies; for reviews see Anderson and Kedersha, 2006;   
Eulalio et al., 2007; Parker and Sheth, 2007). P­bodies, and/or 
the mRNPs within them, have been implicated in mRNA de­
capping,  nonsense­mediated  decay,  mRNA  storage,  general 
translation  repression,  µRNA­mediated  repression,  and  viral   
life  cycles  (for  reviews  see  Anderson  and  Kedersha,  2006;   
Eulalio et al., 2007; Parker and Sheth, 2007). Transcripts within 
P­bodies are in dynamic exchange with the translating pool of 
mRNAs and can either be degraded or can return to translation 
(Brengues et al., 2005; Bhattacharyya et al., 2006).
P­bodies  can  partially  overlap  in  yeast  (Brengues  and 
Parker, 2007; Hoyle et al., 2007; Buchan et al., 2008) or dock in 
mammalian cells (Kedersha et al., 2005; Wilczynska et al., 2005), 
with a second cytoplasmic RNA–protein structure referred to as 
a stress granule. Stress granules are dynamic aggregates of un­
translating mRNAs in conjunction with some translation initia­
tion factors (e.g., eIF4E and eIF4G) and several RNA­binding 
proteins with the precise composition of stress granules depen­
dent on the stress or organism examined (for reviews see 
T
ranslation and messenger RNA (mRNA) degrada-
tion are important sites of gene regulation, particu-
larly  during  stress  where  translation  and  mRNA 
degradation are reprogrammed to stabilize bulk mRNAs 
and to preferentially translate mRNAs required for the 
stress response. During stress, untranslating mRNAs ac-
cumulate  both  in  processing  bodies  (P-bodies),  which 
contain some translation repressors and the mRNA deg-
radation machinery, and in stress granules, which con-
tain mRNAs stalled in translation initiation. How signal 
transduction pathways impinge on proteins modulating 
P-body and stress granule formation and function is un-
known. We show that during stress in Saccharomyces 
cerevisiae, Dcp2 is phosphorylated on serine 137 by the 
Ste20 kinase. Phosphorylation of Dcp2 affects the decay 
of some mRNAs and is required for Dcp2 accumulation 
in P-bodies and specific protein interactions of Dcp2 and 
for  efficient  formation  of  stress  granules.  These  results 
demonstrate that Ste20 has an unexpected role in the 
modulation  of  mRNA  decay  and  translation  and  that 
phosphorylation of Dcp2 is an important control point for 
mRNA decapping.
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Because Dcp2 is the critical catalytic component of the de­
capping enzyme, we examined whether Dcp2 was phosphory­
lated  during  glucose  deprivation  (10  min),  oxidative  stress 
induced by hydrogen peroxide (1 mM for 30 min), or at high 
cell density. We examined Dcp2 phosphorylation by immuno­
purifying Flag­tagged Dcp2 from cells with or without stress 
conditions and then performing a Western blot on the immuno­
purified material with an anti–phospho­Ser–specific antibody.
We observed that hydrogen peroxide exposure, glucose 
deprivation, or growth to stationary phase all led to the appear­
ance of phosphorylated Dcp2 (Fig. 1). In contrast, in mid­log 
cultures, phosphorylated Dcp2 was not detected, although Dcp2 
immunopurified to similar levels as during stress conditions, as 
judged by a Western blot (Fig. 1). These results demonstrate 
that Dcp2 is phosphorylated in response to hydrogen peroxide 
treatment, glucose deprivation, or growth to high cell density.
Ste20 is required for Dcp2 
phosphorylation
To identify protein kinases that potentially phosphorylate Dcp2, 
we focused on protein kinases activated during stress. Previous 
work has shown that oxidative stress activates the yeast MAPK 
pathway, including Ste20, Ste11, Ste7, Fus3, and Kss1. (Staleva 
et al., 2004). Moreover, a genetic screen identified Ste20 as   
being important in stress granule formation in yeast (unpublished 
data). Thus, we hypothesized that Ste20 might be responsible 
for the phosphorylation of Dcp2 during stress, which we tested 
by examining whether Dcp2 was phosphorylated during stress 
in a ste20 strain.
We observed that after hydrogen peroxide treatment, glu­
cose deprivation, or growth to high cell density, the ste20 
strain showed reduced phosphorylation of Dcp2 as compared 
with  a  wild­type  strain  (Fig.  1). Thus,  Ste20  either  directly 
phosphorylates Dcp2 or is required for stress­induced phos­
phorylation of Dcp2 in Saccharomyces cerevisiae by activating 
a downstream kinase. However, strains lacking the Ste11 and 
Ste7 proteins, which are downstream of Ste20 in its canonical 
MAPK pathway, still show phosphorylation of Dcp2 during 
glucose deprivation (Fig. S1), arguing that Ste20 might directly 
phosphorylate Dcp2.
Ste20 can directly phosphorylate Dcp2
To determine whether Ste20 could directly phosphorylate Dcp2, 
we immunopurified Ste20 from yeast and determined whether it 
could phosphorylate recombinant Dcp2 in vitro. In these exper­
iments, a wild­type or kinase­dead mutant allele of Ste20 tagged 
with GFP at its genomic locus (Ahn et al., 2005) was immuno­
precipitated with an anti­GFP antibody. The resulting immuno­
pellet was mixed with the Dcp2 catalytic domain (amino acids 
102–300) purified from Escherichia coli in the presence of 
radioactive ATP. If Ste20 is capable of directly phosphorylating 
Dcp2, Dcp2 phosphorylation should be observed and should be 
dependent on the kinase activity of Ste20.
Incubation of Dcp2 102–300 with the wild­type Ste20   
immunopellet, but not Ste20 kinase­dead allele (K649R), led 
to the labeling of an 130­kD band, which is likely to be auto­
phosphorylation of Ste20­GFP, and a band running at 35 kD 
Anderson  and  Kedersha,  2006;  Buchan  and  Parker,  2009). 
Stress granules are generally not present in normal cells and 
form in response to defects in translation initiation, including 
decreased function of eIF2 or eIF4A (Kedersha et al., 2002; 
Dang et al., 2006; Mazroui et al., 2006), or heat shock or glu­
cose deprivation in yeast (Brengues and Parker, 2007; Hoyle 
et al., 2007; Buchan et al., 2008; Grousl et al., 2009). P­bodies 
also increase during stress in both yeast and mammals presum­
ably because of increases in the pool of nontranslating mRNPs 
(Kedersha et al., 2005; Teixeira et al., 2005; Wilczynska et al., 
2005). At a minimum, the presence of P­bodies and stress gran­
ules serves as microscopic markers for pools of biochemically 
distinct mRNPs, although the additional properties of the larger 
aggregates remain to be identified.
The interaction of P­bodies and stress granules suggests 
that mRNA might be exchanged between these two compart­
ments  in  a  process  involving  remodeling  of  the  composite 
mRNPs. Consistent with that possibility, stress granules in yeast 
during glucose deprivation are dependent on P­bodies for their 
formation and commonly form in association with preexisting 
P­bodies (Buchan et al., 2008). These observations led to the 
suggestion that, at least during glucose deprivation in yeast, 
mRNAs might primarily move from P­bodies to stress granules 
in a process that would require exchange of P­body components 
on the mRNA for the proteins seen associated with the mRNA 
in stress granules such as translation initiation factors (Buchan 
et al., 2008). Such a remodeling of the mRNP would be ex­
pected to impact on the fate of the transcript because transition­
ing from a P­body mRNP to a stress granule state would reduce 
the possibility of mRNA degradation and promote reentry into 
translation. Thus, important and unresolved issues are how   
individual  mRNPs  within  P­bodies  and  stress  granules  are   
remodeled and how external stimuli activate signaling path­
ways to alter these interactions, thereby modulating translation 
and mRNA degradation.
Signaling pathways that activate different MAPKs control 
many  cellular  responses  to  external  cues.  In  Saccharomyces 
cerevisae, three of the MAPK cascades are activated by the 
Ste20 protein kinase, which serves as a MAPKKKK. We now 
show that during stress, Ste20 also directly phosphorylates the 
decapping enzyme on Ser137. Phosphorylation of Dcp2 affects 
the decay of some mRNAs, is required for Dcp2 accumulation 
in P­bodies and specific protein interactions of Dcp2, and for 
efficient formation of stress granules. These results demonstrate 
that Ste20 has an unexpected role in the modulation of mRNA 
decay and translation and that phosphorylation of Dcp2 is an 
important control point for mRNA decapping.
Results
Dcp2 is phosphorylated during stress
Several stresses, including glucose deprivation and growth to 
high cell density, lead to enhanced P­body formation and/or   
inhibition of mRNA degradation, suggesting that some compo­
nents of the mRNA degradation machinery might be modified 
under these conditions (Jona et al., 2000; Benard, 2004; Teixeira 
et al., 2005; Greatrix and van Vuuren, 2006; Hilgers et al., 2006). 815 Phosphorylation of Dcp2 by Ste20 • Yoon et al.
phosphorylation in vitro with immunopurified Ste20 from yeast 
or affinity­purified Ste20 from E. coli. We observed that the ex­
tent of Dcp2 phosphorylation by Ste20 in vitro was reduced after 
either the S137A or S211A mutations (Fig. 2 B and Fig. S1 B).   
Moreover, the double­mutant S137A, S211A, showed almost a 
complete loss to phosphorylation in vitro (Fig. 2 B and Fig. S1 B).   
We interpret these results to indicate that both S137 and S211   
can serve as sites of Ste20 phosphorylation in vitro.
To verify that Dcp2 was phosphorylated by Ste20 on 
Ser137,  we  phosphorylated  Dcp2  in  vitro  with  recombinant 
Ste20 purified from E. coli and analyzed the products by mass 
spectrometry (MS; see Materials and methods). We observed 
phosphorylated peptide fragments corresponding to phosphory­
lation on Ser137 when Dcp2 was incubated with Ste20 and ATP 
(Fig. 2 C). This provides direct evidence that Ste20 phosphory­
lates Dcp2 on Ser137.
In vivo, the specificity of phosphorylation might be influ­
enced by additional factors. Thus, we examined how the S137A 
and S211A mutations affected the phosphorylation of Dcp2 in 
yeast during glucose deprivation. We observed that the S137A 
mutant was no longer phosphorylated, whereas the S211A mu­
tant showed reduced phosphorylation (Fig. 2 D). All proteins 
were equivalently immunopurified based on Western analysis 
for the Flag epitope fused to Dcp2. We also observed that the 
S137A mutant showed reduced phosphorylation after hydrogen 
peroxide treatment, whereas the S211A mutant was phosphory­
lated to levels similar to wild­type Dcp2 (unpublished data). 
These observations argue that S137 is required for phosphory­
lation in vivo by Ste20 and is likely to be the major site of phos­
phoryl group addition by Ste20 in cells. However, there may 
be additional sites, including S211A, that are phosphorylated 
in some stresses. Additional evidence that S137 is the key site 
for phosphorylation during stress is the phenotypes of a charge­
mimetic allele at this position (see below).
Consequences of Dcp2 phosphorylation
The aforementioned results argued that Dcp2 is phosphorylated 
on S137A during stress by Ste20. To determine the role of Dcp2 
phosphorylation, we examined the consequences of mutations 
that either prevent phosphorylation (S137A) or are charge mi­
metic (S137E) on mRNA decapping, the formation of P­bodies, 
and stress granules. In addition, because Ste20 affects Dcp2 
phosphorylation, we also examined the effects of a ste20 in 
these assays. Strikingly, we observed that dcp2 strains ex­
pressing the dcp2­S137A allele grew more slowly than strains 
expressing the wild­type or S137E allele (see Discussion). This 
indicates that phosphorylation of Dcp2 is required for optimal 
growth rate. More detailed experiments to understand the role of 
Dcp2 phosphorylation are described in Materials and methods.
Dcp2 phosphorylation does not generally 
affect decapping
Because Dcp2 is the decapping enzyme, we first asked whether 
alteration of the phosphorylation site affected its catalytic activ­
ity. S137 is located adjacent to, but does not overlap, the active 
site of Dcp2 (She et al., 2006, 2008; Deshmukh et al., 2008). 
Given this, we purified the catalytic domain of Dcp2 from E. coli 
(Fig. 2 A). Although this band is larger than the expected size of 
Dcp2 102–300 (27 kD with tags included), this band comigrates 
with the major Coomassie­stained band in Dcp2 102–300 prep­
arations, which we have verified by excision of the band fol­
lowed by mass spectroscopy to be Dcp2 102–300. Additional 
data that the phosphorylated 35­kD migrating band is Dcp2 
102–300 is the detection of phosphopeptides from Dcp2 after 
kinasing with Ste20 (see below). These results argue that Ste20 
can directly phosphorylate Dcp2, which is confirmed by dem­
onstrating that Ste20 purified from E. coli was also able to phos­
phorylate Dcp2 102–300 (Fig. S1 B).
Ser137 is a target for Dcp2 
phosphorylation in yeast
To determine the significance of Dcp2 phosphorylation, we de­
sired to identify the Ser and/or threonine residues where yeast 
Dcp2 was phosphorylated and then use genetic approaches to 
address the function of phosphorylation. Because the phosphory­
lation sites in vitro were localized in the catalytic domain of 
yeast Dcp2 (residues 102–300), we examined this portion of 
Dcp2 for possible Ste20 phosphorylation sites based on com­
parison with the sites mapped in histone H2B and Ste11 (Wu 
et al., 1995; Ahn et al., 2005). This analysis identified Ser137 
(S137) and 211 (S211) as possible Ste20 phosphorylation sites. 
We tested this possibility by mutating these sites to alanine   
either individually or in combination and examining their 
Figure 1.  Dcp2 is phosphorylated in response to stress in vivo. Wild-type 
(WT) and ste20 strains in the BY4741 background were transformed 
with Flag-Dcp2 expression plasmid (pRP983) and grown to reach OD 
600 of 0.50–0.6. Cells were treated with 1 mM hydrogen peroxide for   
30 min or deprived of glucose for 10 min. For examination at high cell 
density, cells were grown in synthetic media for 48 h. Cell lysates were 
immunoprecipitated (IP) with anti-Flag antibody–conjugated agarose and   
probed with anti—phospho-Ser antibody (pSer; see Materials and methods). 
To detect Flag-Dcp2, the membrane was reprobed with anti-Flag antibody. 
IB, immunoblot.JCB • VOLUME 189 • NUMBER 5 • 2010   816
Figure 2.  Ste20 phosphorylates Dcp2 in vitro and in vivo. (A) GFP-tagged wild-type (WT) or kinase-dead Ste20 (K649R) integrated at the genomic locus 
was immunoprecipitated with anti-GFP antibody. The resulting immunopellets were incubated with Dcp2 catalytic domain (residues 102–300; pRP1211) 
purified from E. coli in the presence of radioactive ATP for 30 min at 30°C. The reaction mixture was subjected to SDS-PAGE and autoradiograph. (B) Dcp2 
S137 and/or S211 residue was mutated to an alanine residue with site-directed mutagenesis (pRP1678, pRP1684, or pRP1685). The recombinant protein 
was purified from E. coli and mixed with Ste20 purified from yeast for in vitro phosphorylation analysis. (C) His-tagged Dcp2 (102–300) was incubated 
with (top) or without (bottom) GST-Ste20 purified from E. coli (pRP2135) in the presence of nonradioactive ATP. The resulting reaction mixtures were di-
gested with trypsin for MS analysis. Product b and y ions were indicated in the peptide sequences and mass spectrum, respectively. Key m/z values were 
indicated to compare mass shift after phosphorylation. The b4, b5, and b6 peptides, which show a shift corresponding to phosphorylation, are marked 
with colored arrows. (D) Plasmids expressing Dcp2 wild type, S137A, or S211A (pRP983, pRP1676, or pRP1682, respectively) were transformed into 
wild-type or ste20 strains. Cells were grown in mid-log phase and exposed to glucose deprivation stress. Cell lysates were examined to detect phosphory-
lated Dcp2 by SDS-PAGE and immunoblot (IB) assay.817 Phosphorylation of Dcp2 by Ste20 • Yoon et al.
different mutant alleles and examined their location during   
mid­log growth and after glucose deprivation.
This experiment revealed the following important obser­
vations. First, we observed that the accumulation of the wild­
type  Dcp2­GFP  protein  in  P­bodies  was  reduced  in  ste20 
strains (Fig. 4). The accumulation of Dcp2­GFP in P­bodies in 
the ste20 was not reduced as much as the accumulation of the 
Dcp2­S137A protein in a wild­type strain. This suggests that 
additional kinases might be able to phosphorylate Dcp2 at low 
levels. Consistent with this possibility, we observed that after long 
exposures, low levels of phosphorylated Dcp2 could be detected 
in the ste20 strain during glucose deprivation (unpublished 
data). Nevertheless, the reduction in Dcp2­GFP accumulation in 
P­bodies in the ste20 strain provides additional evidence that 
phosphorylation of Dcp2 promotes its accumulation in P­bodies 
during stress.
A second important observation was that the charge­mimetic 
dcp2­S137E allele rescued the defect in Dcp2 accumulation seen 
in the ste20 strain (Fig. 4). This observation strongly argues 
that the defect in Dcp2 accumulation in P­bodies in the ste20 
strain is caused by the failure of Dcp2 to get phosphorylated.
A third observation was that the dcp2­S137E mutant did 
not accumulate above normal levels in P­bodies during mid­log 
growth (Fig. 4). This argues that phosphorylation of Dcp2 is not 
sufficient by itself to induce large P­bodies, although Dcp2 
phosphorylation is necessary during stress responses for the ac­
cumulation of Dcp2 in P­bodies.
Dcp2 phosphorylation affects stress 
granule formation but not P-body formation
The aforementioned observations indicated that phosphoryla­
tion of Dcp2 was required for its accumulation in P­bodies dur­
ing stress. This could be because phosphorylation of Dcp2 is 
required for P­bodies to form or because Dcp2 phosphorylation 
specifically affects Dcp2 accumulation in P­bodies. Given this, 
we examined how P­bodies formed in the various Dcp2 alleles 
as well as in ste20 strains using Edc3­mCherry as a marker of 
P­bodies. Moreover, because recent results suggest that P­bodies 
promote the formation of stress granules in yeast (Buchan et al., 
2008), we also examined how the Dcp2­S137A and ­S137E   
alleles and the ste20 affected stress granule formation in the 
same experiments using a Pab1­GFP fusion protein as a marker 
of yeast stress granules (Buchan et al., 2008). Thus, either wild­
type, ste20, or various dcp2 mutant strains were transformed 
with a centromere plasmid expressing Edc3­mCherry (a P­body 
marker) and Pab1­GFP (a stress granule marker) protein fusions 
and their subcellular location examined with and without glucose 
deprivation. These experiments revealed the following points.
First, we observed that dcp2 strains expressing the dcp2­
S137A allele still produced P­bodies as judged by the accumu­
lation of Edc3­mCherry (Fig. 5). Moreover, as seen previously, 
dcp2 strains also formed robust P­bodies during glucose dep­
rivation and formed enhanced P­bodies during mid­log growth, 
presumably caused by a defect in mRNA decapping (Sheth and 
Parker, 2003; Teixeira and Parker, 2007). These results demon­
strate that neither Dcp2 phosphorylation nor Dcp2 itself is re­
quired for P­body formation per se and, therefore, demonstrates 
(residues 102–300) either as wild­type or with the S137A or 
S137E mutations and assayed the catalytic ability of this pro­
tein in vitro with a cap­labeled substrate based on the MFA2 
mRNA. We observed that the S137A or S137E mutation did 
not substantially alter the decapping activity of Dcp2 in vitro   
(Fig. S2). Based on this, we suggest that phosphorylation does 
not directly inhibit or stimulate Dcp2 enzymatic activity.
To examine the effects of these lesions on decapping in 
vivo, we examined the decay of the MFA2pG reporter mRNA, 
which is under control of the GAL promoter, in dcp2 strains 
transformed with plasmids expressing Dcp2 wild type, dcp2­
S137A, or dcp2­S137E. We examined mRNA decay during both 
mid­log growth, in which Dcp2 is generally not phosphorylated 
and mRNA decay is normal, and during glucose deprivation, in 
which Dcp2 is phosphorylated and mRNA decay is inhibited, 
primarily by a block to deadenylation (Hilgers et al., 2006).
We observed that the decay rate of the MFA2pG mRNA 
was largely unaffected by the S137A or S137E alleles of Dcp2 
in both mid­log cultures and during glucose deprivation (Fig. 3 A 
and Fig. S3). However, we did observe that the total levels of 
mRNA were consistently reduced in the S137E strain for unknown 
reasons (≤40% mRNA compared with wild type). Nevertheless, 
the main implication is that Dcp2 phosphorylation on S137 does 
not globally alter mRNA decay in vivo. Similarly, we observed 
that the decay of the MFA2pG reporter was the same in ste20 
and  wild­type  strains  both  in  mid­log  and  stress  conditions 
(Fig. 3 B and Fig. S3). We interpret these results to indicate that 
phosphorylation of Dcp2 does not globally alter mRNA decay, 
although it remains possible that Dcp2 phosphorylation affects 
the decapping of a subset of mRNAs (see below).
Dcp2 phosphorylation affects its 
localization in P-bodies
We also investigated the effect of Dcp2 phosphorylation on the 
subcellular location of Dcp2. During stresses such as glucose 
deprivation and high cell density, Dcp2 accumulates in P­bodies 
(Teixeira et al., 2005). We transformed Dcp2­GFP expression 
plasmids either with or without the S137A, S137E, or S211A 
mutations  in  wild­type  strains  and  examined  the  subcellular   
location of Dcp2 in mid­log cultures as well as those exposed to 
glucose deprivation and grown to stationary phase.
We observed that the Dcp2­S137A­GFP failed to accumu­
late in P­bodies during glucose deprivation and growth to high 
cell density (Fig. 4). In contrast, the Dcp2 wild­type, Dcp2­
S211A, and Dcp2­S137E proteins all accumulated in P­bodies. 
The failure of Dcp2­S137A proteins to accumulate in P­bodies 
is not because of changes in its expression levels (Fig. S4). 
These observations argue that phosphorylation of Dcp2 is 
required for its efficient accumulation in P­bodies.
If Dcp2 phosphorylation is required for its accumulation in 
P­bodies, strains lacking Ste20, which affects Dcp2 phosphoryla­
tion, should also show a defect in the accumulation of Dcp2 in   
P­bodies. Moreover, if this defect is largely caused by the loss of 
Dcp2  phosphorylation,  then  a  charge­mimetic  allele  of  Dcp2 
would be predicted to restore Dcp2 accumulation in P­bodies in a 
ste20 strain. To test these predictions, we transformed a ste20 
strain with GFP­tagged versions of either wild­type Dcp2 or the JCB • VOLUME 189 • NUMBER 5 • 2010   818
phosphorylation  are  required  for  optimal  stress  granule  for­
mation. We also observed that ste20 strains showed reduced 
stress granule formation during glucose deprivation as com­
pared with wild­type cells, although P­bodies formed normally 
in the ste20 strain (Fig. 5). This observation argues that Ste20 
enhances stress granule formation either through phosphorylation 
that phosphorylation of Dcp2 is required for Dcp2 accumula­
tion in P­bodies.
Second,  we  observed  that  Dcp2  wild­type  strains  effi­
ciently formed stress granules, whereas the dcp2 and dcp2­
S137A strains showed reduced accumulation of stress granules 
(Fig. 5, Pab1­GFP). These results suggest that Dcp2 and its 
Figure  3.  Dcp2  phosphorylation  is  not  re-
quired  for  mRNA  decay.  (A)  dcp2  strain 
(yRP1358)  expressing  Gal-MFA2pG  mRNA 
was  transformed  with  centromere  plasmids 
expressing either wild-type, S137A, or S137E 
Dcp2-GFP (pRP1275, pRP1677, or pRP1680, 
respectively;  Coller  and  Parker,  2005;  this 
study). Cells were grown in synthetic media 
containing  galactose,  and  transcription  was 
repressed  by  changing  to  glucose  media.   
At each time point, cells were harvested, and 
total RNA was analyzed by Northern blotting.   
(B)  BY4741  wild-type  or  ste20  was  trans-
formed with GAL-MFA2pG plasmid and grown 
in  minimal  media  with  galactose.  MFA2pG 
transcription was blocked by glucose addition, 
and  MFA2pG  mRNA  levels  were  examined 
over time by Northern blotting.819 Phosphorylation of Dcp2 by Ste20 • Yoon et al.
restore stress granule formation in the ste20 strain. To test 
this possibility, we expressed the wild­type or dcp2­S137E al­
leles in a ste20 strain and examined P­body and stress gran­
ule formation in response to glucose deprivation. We observed 
that  the  ste20  strain  expressing  the  Dcp2­S137E  protein 
showed partially restored stress granule formation as compared 
with the wild­type strain, whereas ste20 strains expressing 
of Dcp2 and/or by phosphorylation of additional proteins. The 
observed changes in Pab1 accumulation were not caused by re­
duction of protein expression (Fig. S4).
The  requirement  for  Dcp2  phosphorylation  for  stress 
granule formation suggests that the requirement for Ste20 in 
stress granule formation is at least in part caused by phosphory­
lation of Dcp2. This predicts that the dcp2­S137E allele would 
Figure 4.  Dcp2 phosphorylation is necessary 
for its accumulation in P-bodies. A wild-type 
(WT)  strain  (BY4741)  was  transformed  with 
wild-type,  S137A,  S137E,  or  S211A  Dcp2-
GFP (pRP1683) plasmids. Cells were grown 
in  synthetic  media  to  mid-log  and  deprived 
of glucose for 10 min or grown to high cell 
density before microscopic examination on a 
microscope. A ste20 strain in the BY4741 
background  was  transformed  with  wild-type 
or S137E Dcp2-GFP plasmid and exposed to 
glucose deprivation or high OD stress. Cells 
having at least one Dcp2 foci were counted by 
ImageJ for quantification (see Materials and 
methods). Error bars indicate SD. Bar, 5 µm.JCB • VOLUME 189 • NUMBER 5 • 2010   820
alters  protein–protein  interactions  within  mRNPs  accumulating   
in P­bodies, and thereby leads to mRNP transitions that transform   
an mRNA into a stress granule mRNP. This possibility is also raised 
by the observation that stress granule formation in S. cerevisiae is 
promoted by preexisting P­bodies (Buchan et al., 2008). Interest­
ingly, the Dhh1 protein, which interacts with Dcp2 (Decker et al.,   
2007) and localizes to P­bodies, is required for optimal stress 
granule formation (Buchan et al., 2008). This suggested a pos­
sible mechanism whereby Dcp2 phosphorylation might alter the 
Dhh1–Dcp2 interaction and thereby affect the ability of Dhh1 to 
promote stress granule formation. Given this, we examined the 
coimmunoprecipitation of wild­type, S137A, and S137E Dcp2 
variants with Dhh1 in wild­type or ste20 strains.
exogenous wild­type Dcp2 still showed a defect in stress gran­
ule formation (Fig. 5). The ability of the charge­mimetic form 
of Dcp2 to restore stress granule formation in the ste20 strain 
provides additional evidence that phosphorylated Dcp2 pro­
motes stress granule formation and also provides strong evi­
dence that at least part of the role of Ste20 in stress granule 
formation is to phosphorylate Dcp2.
Dcp2 phosphorylation is required to 
maintain Dhh1–Dcp2 interactions during 
glucose deprivation
One possible mechanism by which Dcp2 phosphorylation pro­
moted stress granule formation is that Dcp2 phosphorylation   
Figure 5.  Dcp2 phosphorylation affects stress 
granule but not P-body formation. Wild-type 
(WT; BY4742), ste20 (yRP2547), or dcp2 
(yRP1358)  strains  were  transformed  with 
Pab1-GFP/Edc3-mCherry plasmid (pRP1658; 
Buchan et al., 2008), grown to OD 600 of 
0.5–0.6 in synthetic media, and deprived   
of glucose for 10 min before the localization of 
Pab1p-GFP and Edc3p-mCherry were exam-
ined with a microscope. In addition, the dcp2   
strain was transformed with wild-type or S137A 
Flag-Dcp2 plasmid (pRP983 or pRP1676) be-
fore  glucose  deprivation.  The  ste20  strain 
containing Pab1-GFP/Edc3-mCherry plasmids 
was transformed with wild-type or S137E Flag-
Dcp2  (pRP983  or  pRP1679).  Images  were 
quantified as in Fig. 4 and in Materials and 
methods. Error bars indicate SD. Bar, 5 µm.821 Phosphorylation of Dcp2 by Ste20 • Yoon et al.
of mRNA decay rates, we validated that two ribosomal protein 
mRNAs (Rpl26a and Rpp1b) showed slower rates of mRNA 
degradation in the dcp2­S137E strain as compared with either 
wild­type or dcp2­S137A strains (Fig. 7, B and C). Collectively, 
these results argue that phosphorylation of Dcp2 at S137 stabi­
lizes a subclass of mRNAs enriched in ribosomal mRNAs.
Our microarray results also revealed other alterations in 
mRNA levels in response to alterations at S137. We observed 
that there was a class of mRNAs, preferentially enriched in   
mitochondrial function (Fig. 7 A), that were increased in both 
the dcp2­S137E and dcp2­S137A strains as compared with wild­
type and, therefore, may be mRNAs whose degradation is nor­
mally enhanced by S137. We also observed a class of mRNAs, 
preferentially enriched in mRNAs involved in amino acid syn­
thesis or heat response, which were unregulated in the dcp2­
S137A strain and unaffected in the dcp2­S137E strain. Finally, 
we observed a class of mRNAs enriched in iron transporters, 
which were unaffected in the dcp2­S137E strain but down­ 
regulated in the dcp2­S137A strain. Collectively, these results 
indicate that modification of Dcp2 on S137 impacts the levels of 
several mRNAs by both direct and indirect mechanisms.
Discussion
Ste20 modulates mRNA decay by 
phosphorylation of Dcp2
Our observations indicate that Dcp2 is phosphorylated by Ste20 
during certain stresses. Specifically, during glucose deprivation, 
hydrogen  peroxide  exposure  or  growth  to  high  cell  density,   
immunopurified Dcp2 reacts with antibody against phospho­Ser 
in a manner dependent on Ste20 (Fig. 1). Moreover, immuno­
purified or recombinant Ste20 can phosphorylate the catalytic 
region of Dcp2 in vitro on Ser137 as confirmed by MS analysis 
(Fig. 2). Phosphorylation of Dcp2 by Ste20 is primarily on 
Ser137 because mutation of Ser137 to alanine reduces phos­
phorylation of Dcp2 by Ste20 in vitro and in vivo (Fig. 2 B, 
Fig. S1 B, and Fig. S2 D). In addition, substitution of Ser137 
with a charge­mimetic allele, S137E, suppresses some of the 
defects seen in a ste20 strain (Figs. 4 and 5). These results   
reveal an unexpected function of Ste20, modifying the decapping 
enzyme, and demonstrate that activation of Ste20 leads to a bi­
furcated response, whereby phosphorylation of a downstream 
MAPK cascade leads to transcriptional regulation (Herskowitz, 
1995), and Ste20 directly impinges on molecules involved in 
posttranscriptional control, thereby affecting the rates of trans­
lation and/or decay of certain mRNAs.
An unresolved issue is the cellular compartment wherein 
Ste20 phosphorylates Dcp2. Ste20 shuttles between the nucleus 
and cytoplasm, and during oxidative stress accumulates in the 
nucleus (Ahn et al., 2005). Because Dcp2 also shuttles between 
the nucleus and cytosol (Grousl et al., 2009), it could be that 
Ste20 phosphorylates Dcp2 in the nucleus. However, because 
some Ste20 remains in the cytosol during oxidative stress (Ahn 
et al., 2005) and we have not observed accumulation of Ste20 in 
the nucleus during glucose deprivation or growth to high cell 
concentrations (unpublished data), it could be that Dcp2 is phos­
phorylated by cytoplasmic Ste20.
In  wild­type  strains,  we  observed  that  during  mid­log, 
Dhh1 coimmunoprecipitated with Dcp2, and this coimmuno­
precipitation was unaffected by the S137E or S137A alleles. 
This indicates that Dcp2 can interact with Dhh1 independent of 
the phosphorylation status of Dcp2 during mid­log growth. In 
contrast, during glucose deprivation, we observed that the 
S137A allele showed reduced ability to coimmunoprecipitate 
Dhh1, although it was expressed at normal levels (Fig. 6 A). 
Similarly, in ste20 strains, Dhh1 and Dcp2 coimmunoprecipi­
tated during mid­log cultures but showed reduced interaction 
during glucose deprivation (Fig. 6 B). Strikingly, the S137E   
allele of Dcp2 could restore the interaction with Dhh1 during 
glucose deprivation in the ste20 strain. These observations   
argue that the interaction between Dhh1 and Dcp2 is altered 
during stress either directly or indirectly and that phosphoryla­
tion of Dcp2 is required to maintain the interaction of Dhh1 and 
Dcp2 under stress conditions.
The requirement for Dcp2 phosphorylation to maintain 
interactions with Dhh1 and to assemble into P­bodies suggested 
two possible models by which these events could be occurring, 
which can be distinguished by the subcellular location of Dhh1 
during stress. In one model, stress induces translation repres­
sion, forming an initial P­body containing Edc3 and Dhh1 (as 
well as other proteins), then phosphorylated Dcp2 would be re­
cruited to this complex, which predicts that Dhh1 accumulation 
in P­bodies would be independent of Dcp2 phosphorylation. In 
an alternative model, the order of assembly would be formation 
of a P­body containing Edc3 (as well as other proteins), which 
then recruits phosphorylated Dcp2, leading to the recruitment 
of Dhh1, which predicts that Dhh1 accumulation in P­bodies 
would be dependent of Dcp2 phosphorylation. Thus, we exam­
ined the subcellular location of Dhh1­GFP in various mutants 
affecting Dcp2 phosphorylation with or without stress.
Consistent with earlier results (Teixeira and Parker, 2007), 
we observed that Dhh1 accumulated in P­bodies during mid­log 
in a dcp2 strain. More importantly, we observed that Dhh1­
GFP was also present in P­bodies in dcp2­S137A and ste20 
strains (Fig. 6 C). This indicates that Dhh1 recruitment into   
P­bodies is independent of Dcp2 or its phosphorylation status 
and is therefore upstream of Dcp2 recruitment into P­bodies.
Dcp2 phosphorylation affects the 
expression and decay of certain mRNAs
The aforementioned results raised the possibility that phosphory­
lation of Dcp2 might affect the decay of some, but not all, tran­
scripts. To identify mRNAs whose degradation might be affected 
by  Dcp2  phosphorylation,  we  performed  microarray  analysis 
comparing the dcp2­S137E and dcp2­S137A alleles with wild­
type Dcp2, which led to several important observations.
Most importantly, in dcp2­S137E cells, no mRNAs were 
down­regulated  more  than  twofold,  and  40  mRNAs  out  of 
6,200 were up­regulated more than twofold, which suggests 
that Dcp2 phosphorylation stabilizes a subset of mRNAs. Strik­
ingly, the mRNAs up­regulated in the dcp2­S137E stain were 
overrepresented in ribosomal protein mRNAs (Fig. 7 A), sug­
gesting that Dcp2 phosphorylation led to preferential stabiliza­
tion of this class of mRNAs. Moreover, by direct measurement JCB • VOLUME 189 • NUMBER 5 • 2010   822
interactions. First, the S137A allele of Dcp2 fails to accumulate 
in P­bodies during stress, although P­bodies form as judged by 
Edc3p accumulation (Figs. 4 and 5). Second, ste20 strains 
still form P­bodies during glucose deprivation, as judged by   
Dcp2 phosphorylation affects its 
accumulation in P-bodies
Several observations indicate that phosphorylation of Dcp2 by 
Ste20 affects its accumulation in P­bodies and its protein–protein 
Figure 6.  Dcp2 phosphorylation is required for its interaction with Dhh1p during glucose deprivation. (A) Wild-type (WT; BY4742) strains were trans-
formed with expression plasmid of Dhh1-GFP (pRP 1151; Coller et al., 2001) controlled by its own promoter and centromeric replication origin. Again, 
these strains were cotransformed with Flag-tagged wild-type (pRP983), S137A (pRP1676), or S137E (pRP1679) Dcp2 plasmids. Cells were grown in 
synthetic media to reach OD 600 of 0.5–0.6 with or without glucose deprivation for 10 min. Cell lysates were immunoprecipitated (IP) with anti-Flag 
antibody–conjugated beads, and copurified Dhh1p-GFP was detected with anti-GFP antibody after SDS-PAGE. (B) Wild-type or ste20 (yRP2547) strains 
was cotransformed with plasmids expressing Dhh1-GFP and plasmids expressing Flag-tagged wild-type or S137E Dcp2 as indicated. (C) Wild-type, 
ste20, or dcp2 (yRP1358) strains were transformed with a plasmid expressing Dhh1-GFP, or in some cases, the dcp2 strain was cotransformed with 
plasmids expressing Dcp2-WT, S137A, or S137E as indicated. Dhh1 localization was examined with a microscope with or without stress. IB, immunoblot. 
Bar, 5 µm.823 Phosphorylation of Dcp2 by Ste20 • Yoon et al.
Figure 7.  Dcp2 phosphorylation is required for the expression and degradation of certain mRNAs. (A) The schematic of expression microarray analysis 
and gene clustering of 109 genes, which are up-regulated or down-regulated more than twofold in dcp2-S137E or 137A allele. Number of genes found 
in the microarray, total genes involved in specific gene ontology, and p-values were described. (B and C) Dcp2-WT, dcp2-S137A, or dcp2-S137E strains 
(yRP2680, yRP2681, or yRP2682, respectively) were grown in synthetic media containing to reach mid-log. And the cells were incubated with 5 µg/ml 
thiolutin for the indicated times, and total RNA was prepared at each time point for Northern blot analysis of Rpl26a or Rpp1b mRNA. The relative intensity 
of each band was quantified for a half-life measurement with two independent experiments.JCB • VOLUME 189 • NUMBER 5 • 2010   824
An unresolved issue is how phosphorylated Dcp2 promotes 
stress granule formation. One possibility is that when mRNAs are 
exiting translation, they can either assemble an mRNP capable 
of accumulation into stress granules or an mRNP capable of as­
sembling into P­bodies, and that phosphorylated Dcp2 limits the 
accumulation of the P­body type of mRNP, thereby promoting 
stress granule formation. However, three observations make this 
possibility unlikely. First, recent results indicate that P­bodies   
promote the assembly of stress granules in yeast and are not 
in competition with stress granule formation (Buchan et al., 
2008). Second, we observe that dcp2 strains are also defective 
in stress granule formation (Fig. 5), which is inconsistent with 
Dcp2 functioning in competition with stress granule formation. 
Third, we observe that dcp2­S137A and dcp2 strains not only 
show reduced stress granules, they show increased size and in­
tensity of P­bodies in mid­log as judged by Edc3. Given this, 
the simplest interpretation is that phosphorylation of Dcp2 in­
creases the formation of stress granules by affecting remodeling 
of mRNPs within P­bodies and thereby promoting the transition 
of some mRNPs from P­bodies into stress granules, perhaps by 
affecting Dhh1 function, which is required for optimal stress 
granule assembly (Buchan et al., 2008). This model provides a 
possible explanation for why dcp2­S137A strains grow poorly 
(unpublished data). In the absence of Dcp2 phosphorylation, 
some mRNAs will be unable to exit P­bodies and reenter trans­
lation, which is consistent with the small P­body formation in 
S137A strains even during mid­log growth (Fig. 5).
Dcp2 phosphorylation stabilizes some 
mRNAs encoding ribosomal proteins
Several observations argue that phosphorylation of Dcp2 modu­
lates the levels and/or decay of some, but not all, yeast mRNAs. 
Most importantly, microarray analysis of the dcp2­S137E allele 
revealed an increase in a set of mRNAs enriched in ribosomal 
proteins (Fig. 7 A). Moreover, direct measurement of the mRNA 
decay rates of some of these mRNAs revealed that they were 
more stable in the dcp2­S137E strain as compared with either 
wild­type or dcp2­S137A strains (Fig. 7, B and C). However, 
this effect is limited to a subset of mRNA conditions because 
the levels of many mRNAs were not changed in the different 
Dcp2 alleles, and phosphorylation of Dcp2 did not affect the 
decay of the MFA2pG reporter mRNA (Fig. 3). To date, we 
have only been able to examine the effects of Dcp2 phosphory­
lation during mid­log growth because during the stresses we 
have used to date, mRNA deadenylation is also inhibited, and 
bulk mRNA is stabilized (Hilgers et al., 2006), thus obscuring 
our ability to measure the effect of Dcp2 phosphorylation on 
decapping of the total population of mRNAs. However, it is 
likely that the role of Dcp2 phosphorylation under stress would 
be to stabilize the subpopulation of mRNAs that are already 
deadenylated. Because we only analyzed mRNAs that changed 
greater than twofold in our microarray experiments, it is possible 
that additional mRNAs are affected by Dcp2 phosphorylation to 
a smaller degree. Thus, phosphorylation of Dcp2 stabilizes a 
subset of mRNAs, particularly those involved in ribosome bio­
genesis. Because the mRNAs involved in ribosome biogenesis 
represent a large fraction of the total mRNA in the cell, this 
accumulation of Edc3, but fail to recruit Dcp2 to these complexes 
(Fig. 5). Third, the ability of Dcp2 to accumulate in P­bodies 
in the ste20 strain can be restored by the charge­mimetic 
S137E allele of Dcp2 (Fig. 4). Fourth, the dcp2­S137A allele in 
wild­type cells and the wild­type Dcp2 in ste20 strains show 
reduced coimmunoprecipitation with Dhh1 during glucose dep­
rivation (Fig. 6). Moreover, the reduced interaction of Dcp2 and 
Dhh1 in the ste20 strain can be restored by the S137E allele   
(Fig. 6). Thus, phosphorylation of Dcp2 increases its coimmuno­
precipitation with Dhh1 at least during glucose deprivation. 
These results indicate that the phosphorylation of Dcp2 is 
likely to change some aspect of its protein–protein interactions, 
thereby affecting the assembly of an mRNP containing the   
decapping enzyme.
One surprising observation was that the Dhh1–Dcp2 inter­
action is normal during mid­log growth when Dcp2 is not   
phosphorylated, yet requires Dcp2 to be phosphorylated during 
glucose deprivation to maintain the interaction. This could be 
because phosphorylation of Dcp2 is required to counterbalance 
additional modifications to Dhh1 or Dcp2 during stress that di­
rectly reduces their interaction. Alternatively, during stress, Dcp2 
might interact with other factors that compete for Dhh1 binding 
to Dcp2 and that phosphorylation decreases the binding to   
allow Dhh1 to bind more tightly.
Dcp2 phosphorylation promotes stress 
granule formation
Several observations indicate that phosphorylation of Dcp2 
by Ste20 affects the formation of stress granules. First, strains 
lacking Dcp2 or Ste20 show reduced numbers and fainter 
stress granules during glucose deprivation (Fig. 5). This is 
not a result of defects in decapping per se because dcp1 
strains, which are as defective as dcp2 strains in decapping, 
show increased numbers of stress granules during glucose 
deprivation (Buchan et al., 2008). Second, strains with the 
dcp2­S137A allele show a defect in forming stress granules 
(Fig. 5). Third, the defect in stress granule formation in a 
ste20 strain can be partially suppressed by expression of 
the  Dcp2­S137E  protein. This  latter  observation  indicates 
that at least part of the defect in stress granule formation of 
the ste20 strain is the result of a failure to phosphorylate 
Dcp2. These observations demonstrate that Dcp2 is not just 
a decapping enzyme but plays a second role in stress gran­
ule formation in a manner dependent on its phosphorylation. 
This  also  provides  additional  evidence  that  stress  granule 
formation during glucose deprivation in yeast is dependent 
on P­bodies (Buchan et al., 2008).
Our results suggest that Ste20 might also impact stress 
granule formation through additional targets. This possibility is 
based on the observations that although the ste20 strain shows 
dramatically decreased stress granule formation during glucose 
deprivation, a dcp2 strain only has partially reduced stress 
granules. Moreover, the dcp2­S137E allele only partially res­
cued the ste20 defect in stress granule formation. Another 
possible target for Ste20 affecting stress granule formation is 
eIF­4E, which was identified as a substrate for Ste20 in a genome­
wide screen (Ptacek et al., 2005).825 Phosphorylation of Dcp2 by Ste20 • Yoon et al.
To analyze phosphorylation in vivo, cells were grown in synthetic 
media to mid-log (or stationary phases) and harvested with or without de-
scribed stresses. Cells were lysed, and Flag-Dcp2 (Dunckley and Parker, 
1999)  was  purified  as  previously  described  (Beckham  et  al.,  2007). 
Immunopellets were run on SDS-PAGE and subjected to Western analysis 
with antibody against phospho-Ser. Images are representative of three in-
dependent experiments
Microarray analysis
Expression microarray analysis was performed as described previously 
(Capaldi et al., 2008). dcp2 strain was transformed with expression plas-
mid of Dcp2-GFP wild-type, S137A, or S137E mutant. Cells were grown 
in synthetic complete media to reach OD 600 of 0.5–0.6 and frozen 
in dry ice. Total RNA was purified by phenol/chloroform and chloroform 
extraction. 40 µg total RNA was converted into cDNA by SuperScript III 
(Invitrogen) with 40 µg random primer (N9) and amino allyl UTP (Sigma-
Aldrich) and purified with the use of gel extraction kit (QIAGEN). 5 µg 
purified DNA was labeled with NHS ester Cy3 or Cy5 (GE Healthcare) by 
incubating in sodium bicarbonate for 5 h, and the free dye was removed 
by gel extraction kit. 500 ng Cy3- or Cy5-labeled cDNA was hybridized to 
a microarray with 6,200 60-base probes (G4140A arrays; Agilent Tech-
nologies) in hybridization buffer (Agilent Technologies) for 16 h at 65°C 
in rotation chamber. The arrays were washed and scanned with the use 
of a scanner (4000B; Axon). The resulting images were analyzed with 
GenePix, and the all of the files were uploaded to Stanford Microarray   
Database. The further clustering work was performed with Cluster 3.0 
(Eisen Laboratory) and Java Tree view. Two independent microarray analy-
ses were performed (Table S5).
Liquid chromatography tandem MS
Mapping of phosphorylation on Dcp2 in vitro was performed as follows. 
First, His-Dcp2 (102–300) was incubated with or without GST-Ste20 puri-
fied from E. coli for 2 h at 37°C. The reaction mixtures were digested in 
100 mM ammonium bicarbonate by trypsin (10 µg/ml) at 37°C overnight 
as previously described (Flannery et al., 1989). Liquid chromatography 
MS/MS analyses of trypsin-digested proteins were performed using a lin-
ear quadrupole-ion trap mass spectrometer (LTQ; Thermo Fisher Scientific) 
equipped with an HPLC system (Paradigm MS4; Michrom), an autosam-
pler (AS3000; SpectraSystems), and a nanoelectrospray source as de-
scribed previously (Andon et al., 2002; Lantz et al., 2007). Tandem MS 
spectra of peptides were analyzed with a program that allows the correla-
tion of experimental tandem MS data with theoretical spectra generated 
from known protein sequences (TurboSEQUEST version 3.1; Thermo Fisher 
Scientific; Eng et al., 1994). The peak list (DTA files) for the search was 
generated by Bioworks (version 3.1; Thermo Fisher Scientific). Parent pep-
tide mass error tolerance, fragment ion mass tolerance, and criteria used 
for preliminary positive peptide identification are the same as previously 
described (Cooper et al., 2003; Qian et al., 2005). All matched peptides 
were confirmed by visual examination of the spectra. All spectra were 
searched  against  an  S.  cerevisiae  database  (downloaded  October  3, 
2009; National Center for Biotechnology Information) and the primary se-
quence of DCP2. At the time of the search, the S. cerevisiae protein data-
base from contained 64,422 entries. The results were also validated using 
XTandem, another search engine (Craig and Beavis, 2004), and with Scaf-
fold, a program that relies on various search engine results (i.e., Sequest, 
XTandem, and MASCOT) and that uses Bayesian statistics to reliably iden-
tify more spectra (Keller et al., 2002; Nesvizhskii et al., 2003).
Online supplemental material
Fig. S1 shows Dcp2 phosphorylation during glucose deprivation in wild 
type or various deletion strains of MAPK pathway in yeast and in vitro 
phosphorylation assay results with Ste20 purified from E. coli. Fig. S2 
shows in vitro decapping activity of wild-type or charge-mimetic Dcp2.   
Fig. S3 shows the decay rate of MFA2pG during glucose deprivation in 
wild type, Dcp2 mutant alleles, or the Ste20 deletion strain. Fig. S4 shows 
expression level of Dcp2-GFP or Pab1-GFP in various alleles with Western 
blot analysis. Tables S1–S5 detail properties of yeast strains, plasmids, 
and oligonucleotides as well as quantitation of microscopic results and raw 
data of microarray analysis. Online supplemental material is available at 
http://www.jcb.org/cgi/content/full/jcb.200912019/DC1.
We thank C. David Allis for yeast strains and expression plasmid, J. Ross Buchan 
and Carolyn Decker for critical review of the manuscript, Anne Webb for as-
sistance with blind scoring of microscopic images, Carl Boswell for assistance 
with  microscopy,  Andrew  Capaldi  for  the  support  of  microarray  analysis, 
suggests that during stress, Dcp2 phosphorylation contributes to 
the formation of an mRNP that can selectively promote the re­
modeling of this class of mRNPs from a P­body state to a stress 
granule complex. Such a remodeling would be expected to sta­
bilize the mRNA by reducing its interactions with the decap­
ping complex and possibly also promote its subsequent reentry 
into translation. Thus, posttranslational modification of the de­
capping enzyme by Ste20 plays an important role in modulating 
the fate of cytoplasmic mRNAs.
Materials and methods
Yeast strains, growth conditions, plasmids, and oligonucleotides
The list of strains, plasmids, and oligonucleotides used in this work are 
shown in Tables S1, S2, and S3, respectively. Strains were grown at 30°C 
in a shaking water incubator in yeast/extract/peptone medium or synthetic 
medium supplemented with the appropriate amino acid drop out solutions 
and 2% glucose. All site-directed mutagenesis was performed using stan-
dard protocols, and resulting plasmids were verified by sequencing (Wang 
and Malcolm, 1999).
Microscopic analysis
Cells were grown to OD 600 of 0.5–0.6 in synthetic media with 2% glu-
cose. For glucose deprivation, cells were centrifuged and quickly washed 
with synthetic medium lacking glucose. Pellets were resuspended in syn-
thetic medium lacking glucose and incubated for 10 min in a shaking 
water bath at 30°C. Images were collected by a deconvolution microscope 
(Deltavision RT; Applied Precision) with a UPlan S Apo 100× 1.4 NA 
objective (Olympus). 512 × 512–pixel files were acquired with a camera 
(CoolSNAP HQ; Photometrics) by 1 × 1 binning. Z-series images were 
compiled with maximum intensity projections using ImageJ (National In-
stitutes of Health). Each image was blindly randomized and quantified as 
described previously (Buchan et al., 2008). The counting and measure-
ment of foci size were performed using ImageJ with smoothing, threshold-
ing, and analyze particle functions. Quantitation datasets represent the 
analysis of at least two independent experiments with at least 50 cells. The 
details for quantitation are shown in Table S4.
Western blot analysis
Western blots were performed following standard protocols. The following 
antibodies and their sources were used: anti–phospho-Ser antibody (BD), 
anti-Flag antibody (Sigma-Aldrich), anti-GFP antibody (Covance), or anti-
actin antibody (Abcam). Goat anti–mouse HRP (Thermo Fisher Scientific) 
was used as a secondary antibody.
mRNA decay assay
For in vivo mRNA decay assay, cells were grown to reach OD 600 of 
0.5–0.6 in synthetic medium supplemented with either 2% glucose or   
2% galactose at 30°C. Transcription was blocked by transferring cells to   
4%  glucose  media  (when  grown  in  galactose)  by  adding  tetracycline 
(when using a tet-off reporter) or by adding thiolutin (when probing Rpl26a 
or  Rpp1b;  Sigma-Aldrich).  Total  RNA  was  extracted  and  probed  with 
oRP140 (Muhlrad et al., 1994; Caponigro and Parker, 1995), 100 (Caponigro 
et al., 1993), 1479, or 1480. The resulting images were acquired with a 
phosphoimager (Molecular Dynamics) and quantified using 7S RNA as a 
loading control (Caponigro et al., 1993). Images are representative of 
two independent experiments.
Phosphorylation assays
To analyze phosphorylation of Dcp2 in vitro, the catalytic core of Dcp2 
(amino acids 102–300) and Ste20 were purified from E. coli as previ-
ously described (Ahn et al., 2005; She et al., 2006). Ste20 was puri-
fied  from  yeast  using  either  Ste20-TAP  or  Ste20-GFP  fusion  proteins 
(Ahn et al., 2005). The TAP purification method was used as described 
previously (Rigaut et al., 1999). To immunopurify the GFP-tagged pro-
tein, cell lysates were incubated with anti-GFP antibody (AnaSpec) for 
2 h, and IgG-conjugated Sepharose bead (GE Healthcare) was used to 
pull down antibody (Ryoo et al., 2004). The resulting immunopellet was 
washed three times with lysis buffer and mixed with purified recombi-
nant proteins and radioactive ATP in the kinase reaction buffer as de-
scribed previously (Ryoo et. al., 2004).JCB • VOLUME 189 • NUMBER 5 • 2010   826
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